Daniel joined Life Edit Therapeutics to help build and advance the non-viral delivery platform.

Prior to joining Life Edit, Daniel was a Senior Research Associate at Beam Therapeutics in the LNP Discovery and LNP Process Development teams, where he developed LNPs for delivering base editors. He also worked as a Senior Research Associate at Guide Therapeutics (before their acquisition by Beam Therapeutics), developing and validating LNPs for extrahepatic delivery.

Daniel received his M.S. in Bioengineering at the University of Illinois at Chicago, M.S. in Biomedical Engineering at Carnegie Mellon University, and B.S. in Biomedical Engineering from Washington University in St. Louis.